Carregant...

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

BACKGROUND AND OBJECTIVES: The effectiveness and tolerability of tapentadol extended release (ER), a centrally acting analgesic with μ-opioid receptor agonist and norepinephrine (noradrenaline) reuptake inhibitor activities, have been demonstrated in patients with chronic pain, including those switc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Imanaka, Keiichiro, Tominaga, Yushin, Etropolski, Mila, Ohashi, Hiroki, Hirose, Keiichiro, Matsumura, Taka
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4062813/
https://ncbi.nlm.nih.gov/pubmed/24906437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0204-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!